© 2015 – 2026 EIP
Legal • Impressum • Site by Igloo

© 2015 – 2026 EIP
Legal • Impressum • Site by Igloo

Protecting Kids the World Over - good recent case of going beyond just the application > patentable #CIIatIPO

Circumventing a technical problem - exists where method difference rather than hardware difference? #CIIatIPO

"the computer" allegedly does not include software/applications #CIIatIPO

Effect is irrespective of type of data - technical contribution #CIIatIPO

Technical contribution - control outside of computer/system; control of internal computer hardware; a better OS (from Symbian) #CIIatIPO

Question of the day: what is a technical contribution? [from Symbian only applies to computer program exclusion?] #CIIatIPO

1) Method of training a sheepdog would fall foul of 4th step of Aerotel 2) QuestBV @EPO would also fall foul of 4th step #CIIatIPO [only 2]

Construe the claim - look at claim and try to work out what is there - asks practitioners to be clear #CIIatIPO

AT&T - five signposts to give an idea of what is a 'technical contribution' #CIIatIPO

Symbian - patentable if there is a technical contribution #CIIatIPO

Aerotel - new arrangement of equipment patentable in UK #CIIatIPO (original Aerotel case settled before court)

UKIPO like VICOM, Fujitsu - UK likes technical contribution, then CFPH - betting system - 1) is contribution? 2) is patentable? #CIIatIPO

Microsoft Data Transfer T 424/03 - clipboard case & Hitachi, EPO cases also referred to in UK #CIIatIPO

EPO cases: VICOM - image x matrix = patentable; Pension Benefits = method is business method implemented by computer; COMVIK - start of A.56

Going through s.1(2) quickly - "business" exclusion includes administrative methods #CIIatIPO

Nigel & Stephen train UK examiners on excluded subject matter #CIIatIPO - today practitioners are the trainees

Starting w/ Nigel Hanley from @The_IPO - a UK Examiners view of excluded subject matter

@TheCIPA & @The_IPO heading up Computer Implemented Invention Seminar in London - goal is for understanding w/ practitioners #CIIatIPO

See the JIPLP for my article on the Seroquel case in the UK Patents Court http://t.co/e1VphrMr

Brazil Opens Green Patent Fast Track » Green Patent Blog® http://t.co/XzTmb4TQ] target="_blank">http://t.co/XzTmb4TQ] [Now added to EIP Green Map - http://t.co/XzTmb4TQ] target="_blank">http://t.co/XzTmb4TQ]

Brazil Opens Green Patent Fast Track » Green Patent Blog® http://t.co/XzTmb4TQ] target="_blank">http://t.co/XzTmb4TQ] [Now added to EIP Green Map - http://t.co/XzTmb4TQ] target="_blank">http://t.co/XzTmb4TQ]

And finally - more from the USA. US patent reform from Marian Flattery, Finnegan. Suffering from early leavers.

And now for something completely different - FDA Guidelines for biosimilars from Scott Reid of Fitzpatrick Cella harper Scinto

In Chinese invalidation action can only combine claims, cancel claims or delete markush group member. So post-grant amendment limited.

Prior art defence based on primary prior art reference with secondary reference if necessary (if can combine without invention)

In china disclosed but unclaimed features are dedicated to public. Strong prosecution history estoppel as well. Thanks USA.

Chinese Patent law draws from Germany bifurcation, France saisie, uk gilette, US claim construction and equivalents

In China SPC means Supreme People's Court. Not Supplementary Protection Certificate.

From brazil to china - now Benjamin Bai from Allen & Overy

After lunch now Rana Gosain from Daniel on Brazil patent law relating to pharma - how patents reviewed by officials from health ministry

Interesting discussion of rivastigmine case, and brightwake case. Also omnipharm v merial.

Now Sarah Boxall is analysing the similarities and differences between EPO and UK approaches to obviousness.

What is a "defensive" patent. Is it possible to define a type of patent that should in general be objectionable under competition law?

Substitutability different for parallel trade compared with merger cases - practice mostly relates to latter.

And now to learn more about Abuse Of Dominance from Axel Schulz of White & Case. Will this ever be clear? I think not.

Patent Settlement Monitoring Report 2012 due to be issued soon.

Now we hear from Lavinia Teodorescu from DG Competition, European Commission

Starting point for dominance analysis is ATC 3 classification. key issue to analyse is interchangeability. Not based on specific molecules

First up - Bernard McDonald Emergent Biosolutions and Stephen Whitfield Travers Smith on conflict between competition and patent law.

Pharma Patent Lifecycles conference day 2 about to begin. Today focuses on competition law.